journal article·2023-04-12Open access

Stem cell-derived exosome versus stem cell therapy

Kaiyue Zhang, Ke Cheng

Nature Reviews Bioengineering· Volume 1· Issue 9

Abstract

Stem cell therapies are being explored for the treatment of various diseases, including haematological disease, immune disease, neurodegenerative disease, and tissue injuries. Alternatively, stem cell-derived exosomes may provide similar clinical benefits without the biosafety concerns associated with the transplantation of living cells. However, large-scale manufacturing and purification, batch-to-batch variation, and analysis of the complex cargos of exosomes will need to be addressed to enable their clinical translation.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (10)

Show source-provided references
1. Cao, J. et al. Developing standards to support the clinical translation of stem cells. Stem Cells Transl. Med. 10, S85–S95 (2021).10.1002/sct3.13035 ↗
2. Anisimov, S. V., Morizane, A. & Correia, A. S. Risks and mechanisms of oncological disease following stem cell transplantation. Stem Cell Rev. Rep. 6, 411–424 (2010).10.1007/s12015-010-9134-5 ↗
3. Dinh, P. C. et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat. Commun. 11, 1064 (2020).10.1038/s41467-020-14344-7 ↗
4. Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).10.1126/science.aau6977 ↗
5. Popowski, K. D. et al. Inhalable dry powder mRNA vaccines based on extracellular vesicles. Matter 5, 2960–2974 (2022).10.1016/j.matt.2022.06.012 ↗
6. Popowski, K. D. et al. Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung. Extracellular Vesicle 1, 100002 (2022).10.1016/j.vesic.2022.100002 ↗
7. Wang, Z. et al. Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine. Nat. Biomed. Eng. 6, 791–805 (2022).10.1038/s41551-022-00902-5 ↗
8. Jang, S. C. et al. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance. Commun. Biol. 4, 497 (2021).10.1038/s42003-021-02004-5 ↗
9. Lovell-Badge, R. et al. ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. Stem Cell Reports 16, 1398–1408 (2021).10.1016/j.stemcr.2021.05.012 ↗
10. Thery, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).10.1080/20013078.2018.1535750 ↗